GGrantIndex
Sort

261,768 grants matching gene therapy

HLA-G at the Maternal Fetal Interface

$953,587
Joan Sherar Hunt · University Of Kansas Medical Center · P01 · FY2009 · HD

Human Polycystic Kidney Disease

$953,461
University Of Colorado Denver · P01 · FY2002 · DK

The Role of Protein Methylation in Squamous Cell Carcinoma of the Head and Neck

$953,405
Vassiliki Saloura · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Integrated, Individualized, Intelligent Prescribing (I3P)

$953,342
Joshua C. Denny · Vanderbilt University · U01 · FY2015 · HG

Factors Contributing To Immune-Enhanced Disease In The Pathogenesis of RSV

$953,316
Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI

Antibody-based Protection against Flavivirses

$953,281
Michael S. Diamond · Washington University · R01 · FY2021 · AI

Delivery of peptides for inducing voiding associated with neurological retention

$953,265
Lesley Marson · Dignify Therapeutics, Llc · R42 · FY2016 · NS

Functional and translational studies of RUNX1 and CBFB in hematopoiesis

$953,250
Paul Liu · National Human Genome Research Institute · ZIA · FY2018 · HG

Development of Oncomine Professional as a Platform for Biopharmaceutical Research

$953,247
Daniel R Rhodes · Compendia Bioscience, Inc. · R44 · FY2009 · CA

New Paradigms for Targeting Truncal Driver Mutations

$953,025
William G Kaelin · Dana-Farber Cancer Inst · R35 · FY2019 · CA

Computational Tools For Bioinformatics And Genome Analysis

$953,000
John I Powell · Center For Information Technology · ZIA · FY2010 · CT

Vascular Growth and Regeneration

$953,000
Luisa Iruela-Arispe · Northwestern University At Chicago · R35 · FY2021 · HL

A Novel Immunological-Directed Biotherapy for Treating Rheumatoid Arthritis

$952,967
Gary Fanger · Rise Therapeutics, Llc · R44 · FY2025 · AG

Molecular Mechanisms Regulating Mouse Mammary Gland and Human Breast Tumor Cells

$952,930
Esta Sterneck · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Target and antibiotic discovery in Bacillus anthracis

$952,905
Trius Therapeutics, Inc. · R44 · FY2004 · AI

Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma

$952,700
Kristin R Swanson · Mayo Clinic Arizona · U01 · FY2020 · CA

Lymphoma Disease Discovery and Definition

$952,628
Elaine Jaffe · Division Of Clinical Sciences - Nci · ZIA · FY2020 · CA

Immunohistochemistry Core Laboratory

$952,585
Mark Raffeld · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA

Exploring DNA damage response pathways as targets for cancer therapy

$952,560
Junjie Chen · University Of Tx Md Anderson Can Ctr · R35 · FY2023 · CA

p53-mediated metabolic regulation in tumor suppression

$952,560
Wei Gu · Columbia University Health Sciences · R35 · FY2023 · CA

p53-mediated metabolic regulation in tumor suppression

$952,560
Wei Gu · Columbia University Health Sciences · R35 · FY2022 · CA

Resolving the cancer relevance of predisposition gene mutations

$952,518
Fergus Joseph Couch · Mayo Clinic Rochester · R35 · FY2021 · CA

Resolving the cancer relevance of predisposition gene mutations

$952,518
Fergus Joseph Couch · Mayo Clinic Rochester · R35 · FY2020 · CA

The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) Project 2: Preclinical Model for Antiepileptogenic Therapy Screening in Post-traumatic Epilepsy

$952,506
Aristea S Galanopoulou · University Of Southern California · U54 · FY2017 · NS

Epidemiology of the four most frequent cancers following breast cancer

$952,389
Kathleen E Malone · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA